Category: Chemotherapy
-
Mesothelioma and Cancer Patients Who Received Certain Chemotherapy Drugs May be Eligible for Reimbursement
Bristol-Myers Squibb (BMS), a worldwide biopharmaceutical company and manufacturer of many cancer drugs, has agreed to pay $19 million to patients and third-party payor companies (insurance companies) for overcharging for the costs of cancer drugs used for the treatment of lung cancer, mesothelioma and many other forms of cancer. At least one of the drugs …
Label: Chemotherapy
Posted on Thursday, Jan 6, 2011 -
Pittsburgh Physicians Give Hope to Peritoneal Mesothelioma Patients through HIPEC
The University of Pittsburgh Medical Center (UPMC), an $8 billion global health enterprise, is western Pennsylvania’s largest employer, with 50,000 employees based in Pittsburgh alone. It has also performed more hyperthermic intraperitoneal chemoperfusion (HIPEC) procedures than anywhere else in the world. HIPEC is a new, innovative advanced chemotherapy technique to treat patients with abdominal cavity …
Label: Chemotherapy Treatment News
Posted on Monday, Nov 1, 2010 -
Avastin Found Safe in Treatment of Lung Cancer, May be Used in the Future to Treat Mesothelioma
Researchers in Italy conducting a Phase IV study looking at Avastin’s use in a broad, real-life setting for lung cancer patients have found no new safety problems with the drug, and concluded that previous safety issues are no more common in this study than in previous findings. Avastin, with the drug name bevacizumab, is also …
Label: Chemotherapy Treatments
Posted on Monday, Aug 2, 2010
Mike is a licensed attorney and the former editor of North Carolina Lawyers Weekly and South Carolina Lawyers Weekly. He has contributed numerous articles to the North Carolina State Bar Journal and is a co-author of Capital Lawyers, a history of the Wake County (NC) Bar.
Gregory Froom is a licensed North Carolina attorney and the former editor of North Carolina Lawyers Weekly and South Carolina Lawyers Weekly.